Revelation Biosciences, Inc.
REVB
$1.01
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.48M | 14.11M | 10.70M | 12.71M | 5.17M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 201.70K | 92.60K | 53.30K | 123.90K | 186.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 58.00K | -- | -- |
| Total Current Assets | 11.68M | 14.21M | 10.81M | 12.83M | 5.36M |
|
|
|||||
| Total Current Assets | 11.68M | 14.21M | 10.81M | 12.83M | 5.36M |
| Net Property, Plant & Equipment | 782.50K | 807.30K | 740.40K | 23.90K | 35.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 30.90K | 30.90K | 30.90K | -- | -- |
| Total Assets | 12.50M | 15.04M | 11.58M | 12.86M | 5.40M |
|
|
|||||
| Total Accounts Payable | 931.10K | 828.20K | 577.50K | 1.04M | 828.90K |
| Total Accrued Expenses | 759.90K | 468.10K | 1.40M | 819.40K | 739.60K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 189.40K | 120.90K | 23.00K | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 200.00 | 800.00 |
| Total Other Current Liabilities | -- | -- | -- | 200.00 | 800.00 |
| Total Current Liabilities | 1.88M | 1.42M | 2.00M | 1.85M | 1.57M |
|
|
|||||
| Total Current Liabilities | 1.88M | 1.42M | 2.00M | 1.85M | 1.57M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 550.50K | 638.20K | 723.80K | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.43M | 2.06M | 2.72M | 1.85M | 1.57M |
|
|
|||||
| Common Stock & APIC | 65.82M | 65.42M | 58.28M | 57.91M | 48.83M |
| Retained Earnings | -55.75M | -52.43M | -49.42M | -46.91M | -45.00M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 10.07M | 12.99M | 8.86M | 11.00M | 3.83M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 10.07M | 12.99M | 8.86M | 11.00M | 3.83M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 10.07M | 12.99M | 8.86M | 11.00M | 3.83M |
|
|
|||||